Lv11
56 积分 2023-08-03 加入
Interleukin-18 armours antitumour immune effectors
3小时前
待确认
An Armored anti-GPC3 CAR T Therapy for Hepatocellular Carcinoma Enhanced through Multiple Modules
1个月前
已关闭
Structural rewiring of IL-7R dimerization by an oncogenic transmembrane mutation can be reversed by rational design
1个月前
已完结
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
2个月前
已完结
ENHANCING CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY FOR PAEDIATRIC SARCOMA THROUGH CAR T ENGINEERING AND TUMOUR MICROENVIRONMENT REWIRING
2个月前
已完结
Pooled screening for CAR function identifies novel IL-13Rα2-targeted CARs for treatment of glioblastoma
2个月前
已完结
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
2个月前
已完结
Rational design of TGFbRII dominant negative armored GPC3 CAR-T cells for the treatment of hepatocellular carcinoma
3个月前
已关闭
Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1–CH3 fusion protein
3个月前
已完结
CAR-T cell therapy in hepatocellular carcinoma: from mechanistic insights to clinical translation
3个月前
已完结
皖公网安备34019202002308
